The Part-I of “Recent Trends and the Future of Antimicrobial Agents” consists of ten chapters. The first five chapters describe naturally derived antimicrobial compounds/agents such as plant-based antimicrobials (PBAs), enzymes based and antibody-based antibacterial therapeutic and secondary metabolites from plant endophytes. A chapter on antimicrobials from marine microorganisms has been included. Marine microorganisms (bacteria, fungi, actinomycetes, and cyanobacteria) provide numerous bioactive metabolites which are effective against MDR strains. The most challenging resistance phenomena are diseases caused by protozoans like Plasmodium, fungi like Candida sp., MDR bacteria like Mycobacterium and even viruses that are evolving as mutated pathogens and warrant novel strategies to treat these deadly diseases.
A chapter discusses this outlook regarding the host proteins' implications in viral biology and how they could be exploited for treating viral diseases. Thus, the book “Recent Trends and the Future of Antimicrobial Agents” will provide a significantly expanded overview and updated research to a broader context regarding the development of alternative approaches against microbial infections. We believe that the book will cater to the professionals and learners in academia, industry and health services who aim to learn the most significant approaches towards alternatives to existing antimicrobial therapy.
About the editors:
Dr. Tilak Saha is an Associate Professor in the Department of Zoology, University of North Bengal, West Bengal, India. He received his Ph.D. degree in Biotechnology from the University of North Bengal. His main areas of research are medical microbiology, Immune system and host-microbe interaction. Dr. Saha has published research papers in scientific journals such as Scientific Reports, IJSEM, New Journal of Chemistry, Journal of Molecular Liquids etc. He has also published an edited book entitled “Microbes, Environment and Human Welfare” NOVA Science, USA. Dr. Saha is life member of the Indian Immunology Society.
Dr. Manab Deb Adhikari completed his Ph.D. degree in Biotechnology from Indian Institute of Technology Guwahati (India) in 2014. During 2014-2018, he was engaged as a Research Professor in the Department of Chemical and Biological Engineering, Korea University, Seoul, South Korea. He is currently working as Assistant Professor at the Department of Biotechnology, University of North Bengal, West Bengal, India. His current research interest includes Nanobiotechnology, Antibacterials, Drug Delivery, Antimicrobial Peptides and Probiotics and Prebiotics. He is Lifetime member of Society for Biotechnologists (INDIA) and Association of Microbiologists of India (AMI).
Dr. Bipransh Kumar Tiwary is an Assistant Professor and Head of the Department of Microbiology, North Bengal St. Xavier’s College, Rajganj, Jalpaiguri, West Bengal, India. He received his Ph.D. degree in Biotechnology from the University of North Bengal, West Bengal. His main areas of research are biochemistry, medical microbiology, Computer aided drug design, antimicrobials, quorum sensing in bacteria. He has published research articles in scientific journals such as Plos one, RSC Advance, BMC complementary and alternative medicine and Letters in applied Microbiology. He is Lifetime member of Association of Microbiologists of India (AMI), India and Microbiologists Society, India.
Keywords:
Quorum Quenchers, Endophytes, Antimicrobial, Pharmabiotics, Antimicrobial peptides, Antifungal, Quorum Sensing Inhibitors, Phytopharmaceuticals, Host-targeting Antivirals, Short-chain fatty acids, CRISPR-Cas9 technology , Antileishmanial, Secondary metabolites, Natural products, Anti-malaria, Immunotherapy, Tuberculosis, Antibiotic resistance, RNAi, Phytochemicals.
For more information please visit: http://bit.ly/3lirzII